Disc Medicine (IRON) EBT (2020 - 2026)
Disc Medicine's (IRON) quarterly EBT came in at -$63.5 million in Q1 2026, down 86.81% year-on-year from -$481.2 million in Q1 2025, and down 4.98% on a QoQ basis from -$60.4 million in Q4 2025.
Disc Medicine (IRON) EBT (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of EBT data on file, last reported at -$63.5 million in Q1 2026.
- On a quarterly basis, EBT fell 86.81% year-over-year to -$63.5 million in Q1 2026; TTM through Mar 2026 was -$241.3 million, a 107.98% decrease from a year earlier, with the FY2025 full-year figure at -$211.8 million, down 94.33% from the prior year.
- EBT for Q1 2026 stood at -$63.5 million, down from -$60.4 million in the prior quarter.
- Over the last five years, EBT for IRON reached as high as -$9.6 million in Q2 2022 and fell as low as -$63.5 million in Q1 2026.
- Historically, EBT has averaged -$29.8 million across 5 years, with a median of -$26.3 million in 2024.
- On a YoY basis, EBT climbed as much as 46.27% in 2022 and fell as far as 155.96% in 2022.
- Year by year, EBT stood at -$11.2 million in 2022, then plunged by 109.42% to -$23.5 million in 2023, then slipped by 24.35% to -$29.3 million in 2024, then tumbled by 106.42% to -$60.4 million in 2025, then retreated by 4.98% to -$63.5 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$63.5 million in Q1 2026, -$60.4 million in Q4 2025, and -$62.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | -63.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.45 Mn |
| Dec 31, 2025 | -60.44 Mn |
| Sep 30, 2025 | -62.22 Mn |
| Jun 30, 2025 | -55.20 Mn |
| Mar 31, 2025 | -33.97 Mn |
| Dec 31, 2024 | -29.28 Mn |
| Sep 30, 2024 | -26.49 Mn |
| Jun 30, 2024 | -26.29 Mn |
| Mar 31, 2024 | -26.94 Mn |
| Dec 31, 2023 | -23.55 Mn |
| Sep 30, 2023 | -14.10 Mn |
| Jun 30, 2023 | -15.92 Mn |
| Mar 31, 2023 | -22.76 Mn |
| Dec 31, 2022 | -11.24 Mn |
| Sep 30, 2022 | -16.15 Mn |
| Jun 30, 2022 | -9.58 Mn |
| Mar 31, 2022 | -9.85 Mn |
| Dec 31, 2021 | 20.09 Mn |
| Sep 30, 2021 | -18.55 Mn |
| Jun 30, 2021 | -16.42 Mn |